<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	
	>
<channel>
	<title>
	Comments on: GSK shares receive boost on US drug applicaton	</title>
	<atom:link href="https://ukinvestormagazine.co.uk/gsk-shares-receive-boost-on-us-drug-applicaton/feed/" rel="self" type="application/rss+xml" />
	<link>https://ukinvestormagazine.co.uk/gsk-shares-receive-boost-on-us-drug-applicaton/</link>
	<description>UK Investor Magazine provides breaking financial news and investment ideas</description>
	<lastBuildDate>Wed, 05 Feb 2020 14:02:23 +0000</lastBuildDate>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.8.5</generator>
	<item>
		<title>
		By: GlaxoSmithKline round off excellent 2019 with bullish fourth quarter update - UK Investor Magazine		</title>
		<link>https://ukinvestormagazine.co.uk/gsk-shares-receive-boost-on-us-drug-applicaton/#comment-14149</link>

		<dc:creator><![CDATA[GlaxoSmithKline round off excellent 2019 with bullish fourth quarter update - UK Investor Magazine]]></dc:creator>
		<pubDate>Wed, 05 Feb 2020 14:02:23 +0000</pubDate>
		<guid isPermaLink="false">https://ukinvestormagazine.co.uk/?p=24831#comment-14149</guid>

					<description><![CDATA[[&#8230;] A few weeks on, GlaxoSmithKline said that iViiV Healthcare has completed submission of a new drug application to the US Food &#038; Drug Administration, seeking approval of fostemsavir. [&#8230;]]]></description>
			<content:encoded><![CDATA[<p>[&#8230;] A few weeks on, GlaxoSmithKline said that iViiV Healthcare has completed submission of a new drug application to the US Food &amp; Drug Administration, seeking approval of fostemsavir. [&#8230;]</p>
]]></content:encoded>
		
			</item>
		<item>
		<title>
		By: Open Orphan and hVIVO agree tie-up deal - UK Investor Magazine		</title>
		<link>https://ukinvestormagazine.co.uk/gsk-shares-receive-boost-on-us-drug-applicaton/#comment-13813</link>

		<dc:creator><![CDATA[Open Orphan and hVIVO agree tie-up deal - UK Investor Magazine]]></dc:creator>
		<pubDate>Tue, 21 Jan 2020 16:42:10 +0000</pubDate>
		<guid isPermaLink="false">https://ukinvestormagazine.co.uk/?p=24831#comment-13813</guid>

					<description><![CDATA[[&#8230;] Thursday, FTSE100  listed GlaxoSmithKline saw their shares in green after the firm said that ViiV Healthcare has completed submission of a new drug application to the US Food &#038; Drug Administration, seeking approval of [&#8230;]]]></description>
			<content:encoded><![CDATA[<p>[&#8230;] Thursday, FTSE100  listed GlaxoSmithKline saw their shares in green after the firm said that ViiV Healthcare has completed submission of a new drug application to the US Food &amp; Drug Administration, seeking approval of [&#8230;]</p>
]]></content:encoded>
		
			</item>
		<item>
		<title>
		By: GSK announce positive results for Benlysta Phase 3 Test - UK Investor Magazine		</title>
		<link>https://ukinvestormagazine.co.uk/gsk-shares-receive-boost-on-us-drug-applicaton/#comment-13297</link>

		<dc:creator><![CDATA[GSK announce positive results for Benlysta Phase 3 Test - UK Investor Magazine]]></dc:creator>
		<pubDate>Wed, 18 Dec 2019 20:47:02 +0000</pubDate>
		<guid isPermaLink="false">https://ukinvestormagazine.co.uk/?p=24831#comment-13297</guid>

					<description><![CDATA[[&#8230;] Additionally, as part of GSK’s plans to expand into the UK the firm said that it had sent a submission of a new drug application to the US Food &#038; Drug Administration, seeking approval of fostemsavir, through ViiV Healthcare. [&#8230;]]]></description>
			<content:encoded><![CDATA[<p>[&#8230;] Additionally, as part of GSK’s plans to expand into the UK the firm said that it had sent a submission of a new drug application to the US Food &amp; Drug Administration, seeking approval of fostemsavir, through ViiV Healthcare. [&#8230;]</p>
]]></content:encoded>
		
			</item>
		<item>
		<title>
		By: GSK set to rival Johnson &#38; Johnson for multiple myeloma drug - UK Investor Magazine		</title>
		<link>https://ukinvestormagazine.co.uk/gsk-shares-receive-boost-on-us-drug-applicaton/#comment-13261</link>

		<dc:creator><![CDATA[GSK set to rival Johnson &#38; Johnson for multiple myeloma drug - UK Investor Magazine]]></dc:creator>
		<pubDate>Tue, 17 Dec 2019 13:03:26 +0000</pubDate>
		<guid isPermaLink="false">https://ukinvestormagazine.co.uk/?p=24831#comment-13261</guid>

					<description><![CDATA[[&#8230;] last week the firm saw its shares boosted as GSK told the market about the submission of a new drug application to the US Food &#038; Drug [&#8230;]]]></description>
			<content:encoded><![CDATA[<p>[&#8230;] last week the firm saw its shares boosted as GSK told the market about the submission of a new drug application to the US Food &amp; Drug [&#8230;]</p>
]]></content:encoded>
		
			</item>
		<item>
		<title>
		By: Faron Pharmaceuticals shares in green on Clevegen trial progress - UK Investor Magazine		</title>
		<link>https://ukinvestormagazine.co.uk/gsk-shares-receive-boost-on-us-drug-applicaton/#comment-13157</link>

		<dc:creator><![CDATA[Faron Pharmaceuticals shares in green on Clevegen trial progress - UK Investor Magazine]]></dc:creator>
		<pubDate>Wed, 11 Dec 2019 11:59:03 +0000</pubDate>
		<guid isPermaLink="false">https://ukinvestormagazine.co.uk/?p=24831#comment-13157</guid>

					<description><![CDATA[[&#8230;] (INDEXFTSE: UKX) listed GlaxoSmithKline plc (LON: GSK) updated the market saying that they had completed submission of a new drug application to the US Food &#038; Drug Administration, seeking approval of [&#8230;]]]></description>
			<content:encoded><![CDATA[<p>[&#8230;] (INDEXFTSE: UKX) listed GlaxoSmithKline plc (LON: GSK) updated the market saying that they had completed submission of a new drug application to the US Food &amp; Drug Administration, seeking approval of [&#8230;]</p>
]]></content:encoded>
		
			</item>
		<item>
		<title>
		By: Scientists funded by the Bill and Melinda Gates Foundation develop a monthly contraceptive pill - UK Investor Magazine		</title>
		<link>https://ukinvestormagazine.co.uk/gsk-shares-receive-boost-on-us-drug-applicaton/#comment-13039</link>

		<dc:creator><![CDATA[Scientists funded by the Bill and Melinda Gates Foundation develop a monthly contraceptive pill - UK Investor Magazine]]></dc:creator>
		<pubDate>Thu, 05 Dec 2019 15:11:05 +0000</pubDate>
		<guid isPermaLink="false">https://ukinvestormagazine.co.uk/?p=24831#comment-13039</guid>

					<description><![CDATA[[&#8230;] gelatine capsule developed by the US research team offers an alternative to the birth control [&#8230;]]]></description>
			<content:encoded><![CDATA[<p>[&#8230;] gelatine capsule developed by the US research team offers an alternative to the birth control [&#8230;]</p>
]]></content:encoded>
		
			</item>
	</channel>
</rss>
